Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
Clinical trial NCT00687765 · COMPLETED
Trial details
- NCT number
- NCT00687765
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2015-06-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.